The clinical outcome is positive if the acute inflammatory stage is treated appropriately. The clinical outcome is difficult to predict for the chronic atrophic phase, as changes are only partially reversible. One study showed that third-generation cephalosporin therapy for 28 days resulted in partial dissolving to complete fading of the skin lesion.